---
input_text: 'Analgesic management of uncomplicated acute sickle-cell pain crisis in
  pediatrics: a systematic review and meta-analysis. OBJECTIVES: To capture evidence
  of the efficacy and safety of pharmacological analgesia for uncomplicated acute
  sickle-cell pain in pediatric patients compared to placebo. SOURCES OF DATA: Searches
  for key evidence were performed from March 1 to 31, 2018, for randomized controlled
  trials of pharmacological analgesia compared to placebo for uncomplicated acute
  sickle-cell pain in a pediatric sample. The authors searched ten scientific databases
  including, among others, PubMed, MEDLINE, Embase, and Clinicaltrials.gov for this
  systematic review and meta-analysis. SUMMARY OF THE FINDINGS: Four trials (n=227)
  were selected by the inclusion criteria (intranasal fentanyl, intravenous magnesium,
  arginine, and inhaled nitric oxide). The quality of evidence ranged from low to
  moderate for each outcome. Meta-analysis of changes in the ladder of pain score
  (p=0.72), length-of-stay in hospital (p=0.65), and amount of narcotics used during
  the study (p=0.10) showed non-statistically significant differences and a lack of
  amelioration provided by pharmaceutical analgesics in treatment group. The adverse
  events reported that more participants in the intervention arm underwent pain, with
  statistically significant differences at the drug delivery site in studies using
  intranasal fentanyl and intravenous magnesium (p=0.03). CONCLUSIONS: Pharmacological
  analgesia appears to be uncertain in improving the intensity and providing relief
  of acute pain crisis in pediatric patients with sickle-cell anemia. With respect
  to clinical advantage, no decisive deduction about the clinical efficacy may be
  made regarding these medications in acute sickle-cell pain management in the pediatric
  age group.'
raw_completion_output: |-
  primary_disease: acute sickle-cell pain crisis

  medical_actions: pharmacological analgesia; intranasal fentanyl administration; intravenous magnesium administration; arginine administration; inhaled nitric oxide administration

  symptoms: acute pain crisis; pain at the drug delivery site

  chemicals: fentanyl; magnesium; arginine; nitric oxide

  action_annotation_relationships: pharmacological analgesia TREATS acute pain crisis IN acute sickle-cell pain crisis; intranasal fentanyl administration TREATS acute pain crisis IN acute sickle-cell pain crisis (with fentanyl); intravenous magnesium administration TREATS acute pain crisis IN acute sickle-cell pain crisis (with magnesium); arginine administration TREATS acute pain crisis IN acute sickle-cell pain crisis (with arginine); inhaled nitric oxide administration TREATS acute pain crisis IN acute sickle-cell pain crisis (with nitric oxide); intranasal fentanyl administration CAUSES pain at the drug delivery site IN acute sickle-cell pain crisis (with fentanyl); intravenous magnesium administration CAUSES pain at the drug delivery site IN acute sickle-cell pain crisis (with magnesium)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  intravenous magnesium administration CAUSES pain at the drug delivery site IN acute sickle-cell pain crisis (with magnesium)

  ===

extracted_object:
  primary_disease: acute sickle-cell pain crisis
  medical_actions:
    - pharmacological analgesia
    - intranasal fentanyl administration
    - intravenous magnesium administration
    - arginine administration
    - inhaled nitric oxide administration
  symptoms:
    - acute pain crisis
    - pain at the drug delivery site
  chemicals:
    - CHEBI:119915
    - CHEBI:25107
    - CHEBI:29016
    - CHEBI:16480
  action_annotation_relationships:
    - subject: analgesia
      predicate: TREATS
      object: pain crisis
      qualifier: acute sickle-cell pain crisis
      subject_extension: pharmacological
      object_extension: acute
    - subject: intranasal fentanyl administration
      predicate: TREATS
      object: acute pain crisis
      qualifier: acute sickle-cell pain crisis
      subject_extension: CHEBI:119915
    - subject: intravenous magnesium administration
      predicate: TREATS
      object: acute pain crisis
      qualifier: acute sickle-cell pain crisis
      subject_extension: CHEBI:25107
      object_extension: acute
    - subject: <arginine administration>
      predicate: <TREATS>
      object: <acute pain crisis>
      qualifier: <acute sickle-cell pain crisis>
      subject_extension: <arginine>
    - subject: inhaled nitric oxide administration
      predicate: TREATS
      object: acute pain crisis
      qualifier: acute sickle-cell pain crisis
      object_qualifier: with nitric oxide
      subject_extension: CHEBI:16480
      object_extension: acute sickle-cell pain crisis
    - subject: intranasal fentanyl administration
      predicate: CAUSES
      object: pain at the drug delivery site
      qualifier: acute sickle-cell pain crisis
      subject_extension: CHEBI:119915
    - subject: intravenous magnesium administration
      predicate: CAUSES
      object: pain at the drug delivery site
      qualifier: acute sickle-cell pain crisis
      subject_extension: CHEBI:25107
named_entities:
  - id: MAXO:0000756
    label: transfusion
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:35341
    label: steroids
  - id: CHEBI:81579
    label: erythropoietin
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MAXO:0001077
    label: splenectomy
  - id: MAXO:0001001
    label: gene therapy
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MONDO:0000984
    label: Thalassemia
  - id: HP:0001903
    label: anemia
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0031274
    label: hypovolemic shock
  - id: CHEBI:44423
    label: hydroxyurea
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001017
    label: Vaccination
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0001596
    label: hair loss
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000647
    label: chemotherapy
  - id: MONDO:0000001
    label: disease
  - id: CHEBI:15422
    label: Adenosine triphosphate
  - id: CHEBI:19324
    label: 2,3-diphosphoglycerate
  - id: CHEBI:16856
    label: Glutathione
  - id: CHEBI:176783
    label: Vitamin C
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0002870
    label: Obstructive sleep apnoea (OSA)
  - id: HP:0012531
    label: Pain
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: HP:0000112
    label: Kidney disease
  - id: HP:0012594
    label: Microalbuminuria
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003774
    label: End-stage renal disease
  - id: HP:0000716
    label: depression
  - id: HP:0000739
    label: anxiety
  - id: HP:0007760
    label: Sickle cell disease (SCD)
  - id: HP:0001875
    label: neutropenia
  - id: HP:0012234
    label: agranulocytosis
  - id: CHEBI:4356
    label: desferrioxamine (DFO)
  - id: CHEBI:17941
    label: deferiprone (DFP)
  - id: CHEBI:49005
    label: deferasirox (DFX)
  - id: CHEBI:9144
    label: silymarin
  - id: CHEBI:50453
    label: desferrioxamine
  - id: CHEBI:68554
    label: deferiprone
  - id: MONDO:0019402
    label: Thalassemia major
  - id: HP:0012532
    label: chronic pain
  - id: HP:0100639
    label: erectile dysfunction
  - id: CHEBI:71940
    label: Tadalafil
  - id: HP:0001297
    label: stroke
  - id: HP:0000083
    label: Renal failure
  - id: HP:0000488
    label: Retinopathy
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0200023
    label: Priapism
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: CHEBI:15551
    label: Prostaglandin E2
  - id: CHEBI:18248
    label: Iron
  - id: CHEBI:30660
    label: Thyroxine
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: HP:0001923
    label: Hemolysis (reticulocytosis)
  - id: MAXO:0000068
    label: transplantation
  - id: CHEBI:16467
    label: arginine (Arg)
  - id: CHEBI:18211
    label: citrulline (Citr)
  - id: CHEBI:3638
    label: chloroquine
  - id: CHEBI:17929
    label: asymmetric dimethylarginine
  - id: MONDO:0800385
    label: Iron overload
  - id: CHEBI:6456
    label: Lidocaine
  - id: CHEBI:30413
    label: heme
  - id: MAXO:0000819
    label: Blood collection
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: CHEBI:18050
    label: L-Glutamine
  - id: CHEBI:28901
    label: Busulfan
  - id: MONDO:0044753
    label: Lumbar spinal stenosis
  - id: HP:0001945
    label: Fever
  - id: HP:0002094
    label: Dyspnea
  - id: CHEBI:33281
    label: Antibiotics
  - id: HP:0006554
    label: Acute Liver Failure
  - id: HP:0001919
    label: Acute Kidney Injury
  - id: MONDO:0800198
    label: Antibodies of unknown specificity (AUS)
  - id: HP:0002289
    label: Antibodies of unknown specificity (AUS)
  - id: MAXO:0010033
    label: umbilical cord blood transplantation
  - id: CHEBI:16480
    label: Nitric Oxide
  - id: CHEBI:65308
    label: S-nitrosothiol (SNO)
  - id: CHEBI:17334
    label: Penicillin
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0025464
    label: Oxidative stress
  - id: CHEBI:17287
    label: Phosphocreatine
  - id: CHEBI:24838
    label: Inorganic phosphate
  - id: CHEBI:27226
    label: Uric acid
  - id: CHEBI:50443
    label: hematopoietic stem cell (HSC) transplantation
  - id: CHEBI:32599
    label: magnesium sulphate
  - id: CHEBI:25107
    label: magnesium
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0100820
    label: Glomerulopathy
  - id: HP:0000790
    label: Hematuria
  - id: HP:0001635
    label: heart failure
  - id: HP:0100543
    label: Cognitive deficits
  - id: MONDO:0004979
    label: Asthma
  - id: CHEBI:119915
    label: fentanyl
  - id: CHEBI:29016
    label: arginine
